NRF2-SOX4複合体は,肝細胞がんにおけるPSPHを調節し,M2マクロファージの分化を調節する
Chi-Neu Tsai1,2, Ming-Chin Yu2,3, Yun-Shien Lee4
1Graduate Institute of Clinical Medical Science, Chang-Gung University, Taoyuan City, Taiwan.
Cancer gene therapy
|August 26, 2025
まとめ
新しいSOX4-NRF2-PSPH軸は,肝細胞がん (HCC) の代謝と免疫回避を調節する. この経路をターゲットにすることで,がん細胞のサポートと免疫抑制を妨害することで,新しいHCC治療法を提供することができます.
科学分野:
- 腫瘍学
- 分子生物学
- 癌 代謝
背景:
- 肝細胞癌 (HCC) の進行には,代謝の再プログラムと免疫回避が伴う.
- これらのHCCプロセスを駆動するトランスクリプションネットワークは完全に理解されていません.
研究 の 目的:
- HCCにおける代謝と免疫回避を結びつける新しい規制ネットワークを特定する.
- HCCにおけるSOX4,NRF2,およびPhosphoserine Phosphatase (PSPH) の役割を明らかにする.
主な方法:
- タンパク質複合体を確認するための共免疫降水および近接結合測定法.
- ルシフェラーゼレポーターとクロマチンの免疫降水測定法で遺伝子調節を評価する.
- HCC患者データ (TCGAと臨床コホート) の分析
主要な成果:
- SOX4はNRF2とストレス反応複合体を形成し,PSPHの転写を活性化します.
- PSPHはセリン生物合成を促進し,酸化酸化と酸化還元バランスをサポートします.
- SOX4/ NRF2の抑制は,HCC細胞の酸化損傷とソラフェニブ感受性を増加させる.
- PSPH誘発の代謝物は,M2型のマクロファージの分極化を促進し,免疫抑制性腫瘍の微環境を作り出します.
- 高濃度のSOX4/NRF2/PSPHはM2浸透とHCCの予後不良と相関する.
結論:
- 新しいSOX4-NRF2-PSPHの調節ループは,HCCの代謝と免疫調節を結びつける.
- この軸は,HCC治療の潜在的な治療目標を表しています.
関連する概念動画
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Master Transcription Regulators
7.0K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Transducer Mechanism: Nuclear Receptors
1.6K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.6K


